All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
A potential new treatment for ulcerative colitis (ATLAS-UC)
BGB-16673 - BTK-Degrader in combination for Relapsed or Refractory B-Cell Malignancies
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine T
CAMBRIA-2: Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next-Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER /HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
A drug comparison for patients with newly diagnosed with metastatic hormone-sensitive prostate cancer
The purpose of this study is to compare the effects, good or bad of an investigational product, capivasertib added to standard treatments in patients who are newly diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC) and your cancer has low levels of a protein called PTEN (or “PTEN deficiency”).
Do you have Eosinophilic Esophagitis and difficulty swallowing?
A multicentre study of the safety and effectiveness of CC-93538 in adolescent and adult participants with Eosinophilic Esophagitis
CIC-E-301: a potential new combination vaccine for COVID-19 and flu
The Sponsor is developing a combination vaccine that aims to prevent serious illness or infection of both the flu virus and SARS-CoV-2 virus in people who are at least 65 or more years old.
COLLECTiVE202 - A potential new oral treatment for UC
A new treatment for Eosinophilic Esophagitis
A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
Seeking cancer patients with nerve pain
Duloxetine versus pregabalin to treat opioid-resistant nerve pain in cancer patients.
Assessing the effectiveness of DB-1303 in the treatment of HER2-low breast cancer
The purpose of this trial is to assess the effectiveness of DB-1303 in the treatment of hormone receptor positive, HER2-low breast cancer, compared to standard of care.